Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China · Delayed Price · Currency is CNY 15.47
+0.22 (1.44%)
Feb 3, 2026, 3:04 PM CST
SHE:300601 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -100.29 | 201.65 | 861.3 | -132.71 | 1,263 | 679.19 |
Depreciation & Amortization | 310.68 | 310.68 | 201.39 | 200.95 | 404.71 | 92.93 |
Other Amortization | 42.78 | 42.78 | 39.33 | 28.1 | 28.35 | 13.56 |
Loss (Gain) From Sale of Assets | 8.42 | 8.42 | 1.35 | -0.13 | -0.03 | 0.29 |
Asset Writedown & Restructuring Costs | 15.57 | 15.57 | 3.32 | 624.09 | 3.41 | 9.63 |
Loss (Gain) From Sale of Investments | -1.85 | -1.85 | -1.89 | -4.12 | -29.71 | -43.82 |
Provision & Write-off of Bad Debts | 29.74 | 29.74 | 12.49 | 39.64 | 10.45 | 20.32 |
Other Operating Activities | 678.45 | 250.25 | 137.25 | 384.44 | 217.36 | 2.54 |
Change in Accounts Receivable | -20.26 | -20.26 | -417.18 | -488.76 | 273.88 | -796.49 |
Change in Inventory | -79.03 | -79.03 | 8.68 | 220.75 | -746.67 | -209.73 |
Change in Accounts Payable | -183.76 | -183.76 | 111.31 | -130.98 | 146.54 | 451.25 |
Change in Other Net Operating Assets | 86.99 | 86.99 | -3.19 | 9.97 | 29.95 | 126.95 |
Operating Cash Flow | 729.51 | 603.25 | 1,033 | 545.7 | 1,652 | 439.85 |
Operating Cash Flow Growth | 13.36% | -41.61% | 89.32% | -66.97% | 275.65% | -13.02% |
Capital Expenditures | -296.32 | -472.18 | -718.45 | -1,310 | -2,540 | -1,227 |
Sale of Property, Plant & Equipment | 15.86 | 16.15 | 0.96 | 0.08 | 0.19 | 1.02 |
Investment in Securities | 795 | -157.4 | 218 | -1,338 | 1,037 | -2,625 |
Other Investing Activities | 160.42 | 56.74 | 60.62 | 42.01 | 63.2 | 13.73 |
Investing Cash Flow | 674.96 | -556.69 | -438.87 | -2,606 | -1,440 | -3,837 |
Long-Term Debt Issued | - | 212.62 | 379.91 | 529.46 | 3,141 | 91.11 |
Long-Term Debt Repaid | - | -743.15 | -299.43 | -1,070 | -26.48 | -256.02 |
Net Debt Issued (Repaid) | -330.21 | -530.53 | 80.48 | -540.98 | 3,115 | -164.91 |
Issuance of Common Stock | - | - | - | 587.29 | 164.74 | 3,519 |
Repurchase of Common Stock | - | - | -100.99 | -20.55 | - | -0.21 |
Common Dividends Paid | -133.86 | -256.62 | -237.23 | -622.15 | -220.42 | -207.32 |
Other Financing Activities | 9.45 | -13.61 | -160.31 | 131.52 | -607.18 | 632.17 |
Financing Cash Flow | -454.62 | -800.76 | -418.05 | -464.88 | 2,452 | 3,779 |
Foreign Exchange Rate Adjustments | -0.25 | -0.06 | 0.04 | -1.66 | -0.98 | -0.04 |
Net Cash Flow | 949.59 | -754.26 | 176.22 | -2,527 | 2,663 | 381.61 |
Free Cash Flow | 433.19 | 131.07 | 314.65 | -764.7 | -888.15 | -786.81 |
Free Cash Flow Growth | 475.45% | -58.34% | - | - | - | - |
Free Cash Flow Margin | 16.06% | 4.94% | 9.05% | -24.22% | -24.32% | -34.80% |
Free Cash Flow Per Share | 0.36 | 0.12 | 0.28 | -0.69 | -0.80 | -0.73 |
Cash Income Tax Paid | 129 | 122.5 | 85.74 | 185.63 | 38.68 | 149.75 |
Levered Free Cash Flow | 844.99 | -275.34 | 78.23 | -887.61 | -1,972 | -650.92 |
Unlevered Free Cash Flow | 919.93 | -197.76 | 149.3 | -819.5 | -1,938 | -649.46 |
Change in Working Capital | -253.99 | -253.99 | -221.42 | -594.56 | -245.63 | -334.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.